Company
Caristo Diagnostics
CaRi-Heart® technology creates a new paradigm to fight heart attack and other cardiac diseases by uncovering hidden inflammation.
Also known as Caristo Diagnostics Ltd
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- hospitals and healthcare professionals
- Legal name
- Caristo Diagnostics Ltd
- caristo.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
A first-of-its-kind AI solution to quantify coronary inflammation and characterise plaque based on routine Coronary Computed Tomography Angiography (CCTA). CaRi-Heart analysis generates an individualised risk score to aid diagnosis and management of coronary artery disease.
Products
- Web
- CaRi-Heart®
- SaaS
- CaRi-Heart® Technology
Loading relationship preview